2418
M. M. GHANBAIR ET AL.
þ
=
=
(C O), 1524 (C C). EIMS: m=z (%). 268 (M , 100), 239 (62), 180 (98), 104 (69), 77
(70). 1H NMR (300 MHz, CDCl3): d ¼ 6.91–7.82 (10 H, m, CH), 11.10 (1 H, s, NH),
11.82 (1 H, s, NH). 13C NMR (75 MHz, CDCl3): d ¼ 74.2 (C), 127.7 (2CH), 127.9 (4
=
=
CH), 129.5 (4 CH), 131.4 (2 C), 162.6 (C O), 180.5 (C S).
2-Thioxo-5,5-dip-tolylimidazolidin-4-one (4b). White powder; mp 94–
96 ꢀC; yield: 0.29 g (97%); IR (KBr) (nmax=cmꢁ1): 3244 (NH), 1760 (C O), 1520
=
=
(C C). Anal. calcd. (%) for C17H16N2OS (296.10): C, 68.89; H, 5.44; N, 9.45; S,
10.82. Found: C, 68.97; H, 5.36; N, 9.61; S, 10.51. EIMS: m=z (%) 296 (Mþ, 100),
253 (80), 211 (40), 194 (90), 91 (73), 65 (38). 1H NMR (300 MHz, CDCl3):
d ¼ 2.22 (6 H, s, 2 Me), 6.80–7.73 (8 H, m, CH), 11.28 (1 H, s, NH), 12.10 (1 H,
s, NH).13C NMR (75 MHz, CDCl3): d ¼ 21.3 (2 Me), 74.2 (C), 127.9 (4 CH),
=
=
129.5 (4 CH), 135.4 (2 C), 137.7 (2 C), 162.6 (C O), 180.5 (C S).
5,5-Bis(2-chlorophenyl)-2-thioxoimidazolidin-4-one (4c, C15H10N2OSCl2).
Yellow powder; mp 135–137 ꢀC; yield: 0.31 g (93%); IR (KBr) (nmax=cmꢁ1): 3150
1
=
=
(NH), 1750 (C O), 1524 (C C). H NMR (300 MHz, CDCl3): d ¼ 7.27–7.80 (8 H,
m, CH), 11.30 (1 H, s, NH), 12.20 (1 H, s, NH). 13C NMR (75 MHz, CDCl3):
d ¼ 74.6 (C), 127.8 (2 CH), 127.9 (2 CH), 129.5 (2 CH), 129.9 (2 CH), 133.4 (2 C),
=
=
141.4 (2 C), 162.6 (C O), 180.5 (C S).
5,5-Bis(4-chlorophenyl)-2-thioxoimidazolidin-4-one (4d, C15H10N2OSCl2).
White powder; mp 234–236 ꢀC; yield: 0.32 g (96%); IR (KBr) (nmax=cmꢁ1): 3150
1
=
=
(NH), 1690 (C O), 1524 (C C). H NMR (300 MHz, CDCl3): d ¼ 7.27–7.90 (8 H,
m, CH), 11.40 (1 H, s, NH), 12.32 (1 H, s, NH). 13C NMR (75 MHz, CDCl3):
=
d ¼ 77.4 (C), 129.3 (4 CH), 129.9 (4 CH), 131.5 (2 C), 138.4 (2 C), 162.6 (C O),
=
180.8 (C S).
5,5-Bis(2-nitrophenyl)-2-thioxoimidazolidin-4-one (4e). Brown powder;
mp 168–170 ꢀC; yield: 0.34 g (95%); IR (KBr) (nmax=cmꢁ1): 3050 (NH), 1690
=
=
(C O), 1524 (C C). Anal. calcd. (%) for C16H12N4O5S (372.36): C, 51.61; H,
3.25; N, 15.05; S, 8.61. Found: C, 50.92; H, 3.38; N, 15.21; S, 9.11. 1H NMR
(300 MHz, CDCl3): d ¼ 7.20–7.90 (8 H, m, CH), 9.20 (1 H, s, NH), 11.91 (1 H, s,
NH).13C NMR (75 MHz, CDCl3): d ¼ 74.0 (C), 127.2 (2 CH), 129.9 (2 CH), 135.5
=
=
(2 CH), 138.4 (2 C), 148.5 (2 C), 172.6 (C O), 181.5 (C S).
5,5-Bis(4-nitrophenyl)-2-thioxoimidazolidin-4-one (4f). Brown powder;
mp 265–266 ꢀC; yield: 0.35 g (98%); IR (KBr) (nmax=cmꢁ1): 3150 (NH), 1700
=
=
(C O), 1520 (C C). Anal. calcd. (%) for C16H12N4O5S (372.36): C, 51.61; H,
3.25; N, 15.05; S, 8.61. Found: C, 48.98; H, 3.36; N, 15.61; S, 8.41. 1H NMR
(300 MHz, CDCl3): d ¼ 7.27–7.80 (8 H, m, CH), 9.30 (1 H, s, NH), 11.89 (1 H, s,
NH).13C NMR (75 MHz, CDCl3): d ¼ 74.2 (C), 121.7 (4 CH), 129.9 (4 CH), 145.5
=
=
(2 C), 146.4 (2 C), 174.6 (C O), 181.9 (C S).
3-Methyl-5,5-diphenyl-2-thioxoimidazolidin-4-one (4g). White powder;
mp 94–96 ꢀC; yield: 0.25 g (90%); IR (KBr) (nmax=cmꢁ1): 3286 (NH), 1711 (C O),
=
=
1499 (C C). Anal. calcd. (%) for C16H14N2OS (282.36): C, 68.06; H, 5.00; N,
9.92; S, 11.36. Found: C, 67.90; H, 5.06; N, 9.82; S, 11.41. EIMS: m=z (%) 282
(Mþ, 100), 225 (8), 193 (3), 180 (54), 167 (37), 105 (32), 77 (30). 1H NMR
(300 MHz, CDCl3): d ¼ 3.14 (3 H, s, Me), 7.07–7.19 (10 H, m, CH), 7.90 (1 H, s,